Navigation Links
Frost & Sullivan's Advanced Medical Technologies Research Tracks Opportunities in Markets Influenced by Dynamic Care Pathways

MOUNTAIN VIEW, Calif., March 21, 2012 /PRNewswire/ -- As the diverse areas of healthcare forge ahead into overlapping mechanisms and treatments, so too must medical technologies reform to solve several challenges via streamlined remedies.  To align the market drivers and restraints into an interpretable roadmap, Frost & Sullivan releases the Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012 compendium.  This resource includes Frost & Sullivan's Advanced Medical Technologies proposed key research for 2012, as well as the profiling of recent content over the last two years. 

If you are interested in receiving the complimentary Frost & Sullivan Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012 compendium, please send an email to Britni Myers, Corporate Communications, at, with your full name, company name, job title, telephone number, company email address, company Web site, city, state and country.

Organizations successfully competing in today's healthcare market must consistently review their product and service portfolio to drive value for their partners and clients.  Particularly for those companies in the medical technologies space, they must work to outline interweaved opportunities between several key segments, including medical devices, patient monitoring and medical imaging, to discover how they are and can work together.  The Frost & Sullivan compendium addresses these vital markets, delineating research that casts light on these shadowy, crossover areas to reveal underlying opportunities.

"Stakeholders in the healthcare ecosystem need to track and benchmark business performance across their core products and solutions portfolios," said Frost & Sullivan Advanced Medical Technologies Global Program Leader Siddharth Saha.  "Concurrently, original equipment manufacturer's (OEM's), suppliers and distributors cannot afford to ignore developments in diagnostics, therapeutics and monitoring that can positively or negatively influence the adoption of their core solution."

Frost & Sullivan finds that healthcare solution and service suppliers are increasingly looking to absorb niche technologies into their overall plan.  Optimum healthcare delivery must absorb equipment, devices, materials and service lines with the end goal of enhancing outcomes for patients, caregivers and provider organizations in healthcare.  This creates implications for product and solution areas, as well as care locations.

"In pursuing their growth objectives, healthcare stakeholders are looking beyond their core customer and target verticals, and actively assessing new geographic markets to open up dialog with complementary solution providers," said Saha. "Synergies in portfolio and business strategies can yield much needed return as suppliers look beyond saturated markets. Tracking the new needs of the ultimate end user in the care pathway, while also understanding the decision making structure, helps make a smoother transition to new business realities."

This interactive compendium allows users to foresee tentative 2012 research titles, with planned updates throughout the year to provide the timeliest and most accurate picture of existing and upcoming Advanced Medical Technologies research.  In addition to the titles slated for 2012, the compendium also offers existing research information for 2010 and 2011 as well.  Additionally, for each of the research titles released in 2011 and 2012, an abstract and table of contents for each analysis is provided.  The included titles span the medical imaging, medical devices and patient monitoring spaces.     

The Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012 compendium profiles research within the global Advanced Medical Technologies Growth Partnership Services program, which also includes the following research: Compression Therapy Devices Market in Western Europe, Analysis of the U.S. Multiparameter Patient Monitoring Equipment Market, Analysis of the Orthopedic Implants Market—The Future of Joint Replacements, Custom Procedure Trays and Packs Move Toward Standardization, and Operating Rooms of the Future: A European Perspective.  All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit

Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012


Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivans Global Healthcare Approach Evolves to Contend with Todays Challenges
2. Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device
3. Frost & Sullivan Lauds Siemens Healthcares Unique, Multipurpose Gamma Camera that Sets it Apart from the Competition in the Nuclear Cardiology Market
4. A Secret to Ward Off Jack Frosts Drying Effect on Your Skin: The AmLactin® Family of Moisturizers
5. Frost and Sullivan Recognizes AT&Ts Innovative mHealth Strategy
6. Frost & Sullivan Honors Acuo Technologies with Product Leadership Award in Medical Imaging Informatics
7. KJAYA Medical Honored with 2011 Frost & Sullivan Award for Technology Innovation in Web-based Medical Imaging Data Management
8. Frost & Sullivan Speaks Candidly with U.S. Pharmacists
9. Frost & Sullivan Honors ZONARE for Ultrasound Innovation
10. Awarepoint Corporation Receives Frost & Sullivans 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award
11. China Medicine Corporation Dismisses Frazer Frost as Auditor
Post Your Comments:
(Date:10/11/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers were ... innovative way to use nonlinear optical imaging to confirm ... drugs. A ... show how researchers from BioPharmX and the Wellman Center ... a suite of imaging techniques in what is called ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):